What Works to Prevent Violence Against Women and Girls in Somalia
Launched by JOHNS HOPKINS UNIVERSITY · Aug 12, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Communities Care (CC), which aims to prevent violence against women and girls in Somalia. The program has shown promise in changing harmful attitudes and improving access to support services for women and girls. This trial will adapt the CC program to include both adults and adolescents, focusing on groups in the Banadir and Galmudug regions. The goal is to see how well the program works in improving the safety and support for women and girls.
To participate in this study, individuals must be at least 10 years old and live in specific districts where the program is being implemented. Participants will either be involved in the CC adult or CC adolescent programs through local schools or be community members who do not participate in the programs. Those who join can expect to take part in surveys and discussions to help researchers understand the program's impact over two years. This study is important because it not only aims to reduce violence but also seeks to involve the whole community in creating a safer environment for everyone.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Age 10 years or older
- • Participant in CC adult or CC adolescent program in collaboration with 9 public schools in districts randomized to intervention or control in two regions of Somalia
- • Living/resident of target districts (including internally displaced persons (IDPs) and does not have plans to move/leave the district or surrounding area in the next 12 months (this is critical for the longitudinal data collection with CC program participants)
- Exclusion Criteria:
- • Less than 10 years old
- • Not a participant in CC adult or CC adolescent
- • Not a resident of target districts-
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mogadishu, Wadajir District, Somalia
Patients applied
Trial Officials
Nancy Glass, PhD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported